High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 57, Issue 11, 2008, Pages 1533-1538

  Hsieh, Ming Chia ^a   Tien, Kai Jen ^b   Chang, Shun Jen ^c   Perng, Daw Shyong ^d   Hsiao, Jeng Yueh ^a   Chen, Yu Wen ^e   Chang, Yu Hung ^a   Kuo, Hsuan Wen ^a   Lin, Pi Chen ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; IMAGING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK; SCREENING; SILENT MYOCARDIAL ISCHEMIA;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EXERCISE TEST; FEMALE; HEART; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 53649106254     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.06.007     Document Type: Article

References (48)

1. Young L.H., and Chyun D.A. Heart disease in patients with diabetes (2002), McGraw-Hill, New York
2. Rosamond W.D., Chambless L.E., Folsom A.R., Cooper L.S., Conwill D.E., Clegg L., et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339 (1998) 861-867
3. Hurst R.T., and Lee R.W. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med 139 (2003) 824-834
4. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MISAD) Group. Am J Cardiol 79 (1997) 134-139
5. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 21 (1998) 1551-1559
6. Cohn P.F. Prognosis for patients with different types of silent coronary artery disease. Circulation 75 (1987) II33-II35
7. Laukkanen J.A., Kurl S., Lakka T.A., Tuomainen T.P., Rauramaa R., Salonen R., et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 38 (2001) 72-79
8. Wackers F.J., Young L.H., Inzucchi S.E., Chyun D.A., Davey J.A., Barrett E.J., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 (2004) 1954-1961
9. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
10. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
11. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
12. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
13. Lloyd-Jones D.M., et al. Narrative review. Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145 (2006) 35-42
14. Anand S.S., Razak F., Yi Q., Davis B., Jacobs R., Vuksan V., et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 24 (2004) 1509-1515
15. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
17. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17 (1997) 2167-2176
18. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., and Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167 (2003) 73-79
19. Di Napoli M., and Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 34 (2003) 2922-2929
20. Takeda T., Hoshida S., Nishino M., Tanouchi J., Otsu K., and Hori M. Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 169 (2003) 155-158
21. Fuell D.L., Greenberg A.S., Haffner S., and Chen H. The effect of treatment with rosiglitazone on C-reactive protein and interleukin-6 in patient with type 2 diabetes. Diabetes 50 (2001) A435
22. Cushman M., Legault C., Barrett-Connor E., Stefanick M.L., Kessler C., Judd H.L., et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation 100 (1999) 717-722
23. Tso D.K., and Moe G. Cardiovascular disease in Chinese Canadians: a case-mix study from an urban tertiary care cardiology clinic. Can J Cardiol 18 (2002) 861-869
24. Mak K.H., Chia K.S., Kark J.D., Chua T., Tan C., Foong B.H., et al. Ethnic differences in acute myocardial infarction in Singapore. Eur Heart J 24 (2003) 151-160
25. Chi Z.S., Lee E.T., Lu M., Keen H., and Bennett P.H. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO multinational study of vascular disease in diabetes. Diabetologia 44 Suppl 2 (2001) S82-S86
26. Wang H.Y., Gao P.J., Ji K.D., Shen W.F., Fan C.L., Lu L., et al. Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease. Hypertens Res 30 (2007) 133-141
27. Yen M.L., Yang C.Y., Yen B.L., Ho Y.L., Cheng W.C., and Bai C.H. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol 110 (2006) 191-198
28. Pu L.J., Lu L., Xu X.W., Zhang R.Y., Zhang Q., Zhang J.S., et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 5 (2006) 27
29. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
30. Scognamiglio R., Negut C., Ramondo A., Tiengo A., and Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47 (2006) 65-71
31. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., and Stern M.P. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study. Circulation 110 (2004) 1251-1257
32. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
33. Gazzaruso C., Solerte S.B., De Amici E., Mancini M., Pujia A., Fratino P., et al. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am J Cardiol 97 (2006) 236-239
34. Inoguchi T., Yamashita T., Umeda F., Mihara H., Nakagaki O., Takada K., et al. High incidence of silent myocardial ischemia in elderly patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 47 (2000) 37-44
35. Felsher J., Meissner M.D., Hakki A.H., Heo J., Kane-Marsch S., and Iskandrian A.S. Exercise thallium imaging in patients with diabetes mellitus. Prognostic implications. Arch Intern Med 147 (1987) 313-317
36. Vanzetto G., Halimi S., Hammoud T., Fagret D., Benhamou P.Y., Cordonnier D., et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 22 (1999) 19-26
37. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Cabico J.A., Friedman J., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
38. Hachamovitch R., Berman D.S., Kiat H., Bairey C.N., Cohen I., Cabico A., et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 28 (1996) 34-44
39. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
40. Mieres J.H., Shaw L.J., Hendel R.C., Miller D.D., Bonow R.O., Berman D.S., et al. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease-the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. J Nucl Cardiol 10 (2003) 95-101
41. Berman D.S., Kang X., Hayes S.W., Friedman J.D., Cohen I., Abidov A., et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 41 (2003) 1125-1133
42. Giri S., Shaw L.J., Murthy D.R., Travin M.I., Miller D.D., Hachamovitch R., et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105 (2002) 32-40
43. Vanzetto G., Ormezzano O., Fagret D., Comet M., Denis B., and Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 100 (1999) 1521-1527
44. Snader C.E., Marwick T.H., Pashkow F.J., Harvey S.A., Thomas J.D., and Lauer M.S. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol 30 (1997) 641-648
45. Machecourt J., Longere P., Fagret D., Vanzetto G., Wolf J.E., Polidori C., et al. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 23 (1994) 1096-1106
46. Kamal A.M., Fattah A.A., Pancholy S., Aksut S., Cave V., Heo J., et al. Prognostic value of adenosine single-photon emission computed tomographic thallium imaging in medically treated patients with angiographic evidence of coronary artery disease. J Nucl Cardiol 1 (1994) 254-261
47. Groutars R.G., Verzijlbergen J.F., Muller A.J., Ascoop C.A., Tiel-van Buul M.M., Zwinderman A.H., et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 7 (2000) 333-341
48. Mieres J.H., Shaw L.J., Arai A., Budoff M.J., Flamm S.D., Hundley W.G., et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111 (2005) 682-696